The Amyloidosis Channel on VJHemOnc is an independent medical education platform, supported with funding from Prothena (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
BSH 2022 | The importance of raising awareness and early diagnosis in amyloidosis
Scarlett McNally, BSc, MB, BChir, FRCS(Tr&Orth), MA, MBA, FAcadMed, East Sussex Healthcare NHS Trust, Sussex, UK, discusses the importance of early diagnosis in amyloidosis from a patient perspective. Dr McNally explains that raising awareness of amyloidosis and improving technologies are allowing patients to be diagnosed earlier, which results in improved outcomes for patients. This interview took place at the 62nd Annual Scientific Meeting of the British Society for Haematology (BSH) 2022, in Manchester, UK.
